Victory Capital Management Inc Tyra Biosciences, Inc. Transaction History
Victory Capital Management Inc
- $95.7 Billion
- Q4 2024
A detailed history of Victory Capital Management Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 56,640 shares of TYRA stock, worth $575,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,640
Previous 30,080
88.3%
Holding current value
$575,462
Previous $707,000
11.32%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TYRA
# of Institutions
112Shares Held
43.1MCall Options Held
3.8KPut Options Held
6K-
Ra Capital Management, L.P. Boston, MA10.6MShares$108 Million2.39% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$42.5 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$41.5 Million89.47% of portfolio
-
Nextech Invest Ag4.06MShares$41.2 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$40.1 Million2.05% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $426M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...